![Paul McInulty](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profil
Paul McInulty currently works at Arvinas, Inc., as Senior Vice President-Regulatory Affairs from 2022.
Mr. McInulty also formerly worked at Bristol Myers Squibb Co., as Vice President-Therapeutic Head & Hematology and Celgene Corp., as Vice President-Regulatory Affairs.
Mr. McInulty received his undergraduate degree from The University of Sheffield.
Aktive Positionen von Paul McInulty
| Unternehmen | Position | Beginn |
|---|---|---|
| ARVINAS, INC. | General Counsel | 03.10.2022 |
Ehemalige bekannte Positionen von Paul McInulty
| Unternehmen | Position | Ende |
|---|---|---|
| CELGENE | General Counsel | - |
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | - |
Ausbildung von Paul McInulty
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
29
Beziehungen ersten Grades
4
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 4 |
|---|---|
Bristol Myers Squibb Co.
 Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
Celgene Corp.
 Celgene Corp. BiotechnologyHealth Technology Develops cancer and immunology drugs | Health Technology |
The University of Sheffield
 The University of Sheffield Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Arvinas, Inc.
 Arvinas, Inc. BiotechnologyHealth Technology Engages in discovery, development and commercialization of therapies to degrade disease-causing proteins | Health Technology |
